Brief: Eurocine Vaccines: Final Results From Preclinical Study With Chlamydia Vaccine
May 7 (Reuters) - Eurocine Vaccines AB EUCI.TE :
* PRESENTS FINAL RESULTS FROM PRECLINICAL STUDY WITH
CHLAMYDIA
VACCINE
* STUDY SHOWS THE VACCINE IS VERY IMMUNOGENIC IN BOTH LOW
AND
HIGH DOSE
Source text: https://cisn.co/2YJj9w6
Further company coverage: EUCI.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Nidhogg Resources Holding AB (publ)
See all newsBrief: Nidhogg Resources Holding Resolves On A Directed Set-Off Share Issue
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate